SCHEMBL5145181

SCHEMBL5145181

CCOC(=O)C(=O)C(C(=O)OCC)c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 2/20 0.40
MMP8 P22894 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ALOX5 P09917 1/20 0.38
KEAP1 Q14145 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
HPGD P15428 1/20 0.37
RORC P51449 1/20 0.37
PKM P14618 2/20 0.36
TSHR P16473 1/20 0.36
PIN1 Q13526 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12264634 0.92 MMP8 (0.43) ALDH1A1KDM4EMMP8SMN1; SMN2HSD17B10
SCHEMBL1432886 0.89 MMP8 (0.45) ALDH1A1KDM4EMMP8SMN1; SMN2HSD17B10
Hydrochloric Acid SCHEMBL28191013 0.86 MMP8 (0.43) ALDH1A1KDM4EMMP8SMN1; SMN2HSD17B10
SCHEMBL6317495 0.84 MMP8 (0.42) ALDH1A1KDM4EMMP8SMN1; SMN2HSD17B10
SCHEMBL7324199 0.83 ALOX5 (0.42) ALDH1A1KDM4ESMN1; SMN2HSD17B10ALOX5
Pyridine SCHEMBL28854067 0.81 MMP8 (0.42) ALDH1A1KDM4EMMP8SMN1; SMN2HSD17B10
SCHEMBL5143523 0.79 ALDH1A1 (0.46) ALDH1A1KDM4EMMP8SMN1; SMN2HSD17B10
SCHEMBL2474796 0.79 NPC1 (0.47) ALDH1A1MMP8SMN1; SMN2HSD17B10KEAP1
SCHEMBL26066472 0.78 ALDH1A1 (0.45) ALDH1A1MMP8HSD17B10KMT2APKM
SCHEMBL3407961 0.78 ALOX5 (0.45) ALDH1A1KDM4ESMN1; SMN2HSD17B10ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7301031-B2 Methods for producing hydroxy amino acids, esters, and derivatives thereof BIOCATALYTICS, INC. (US) 2007-11-27 US disclosed
US-7081535-B2 Hydroxy-amino acids BIOCATALYTICS, INC. (US) 2006-07-25 US disclosed
US-20050192439-A1 Methods for producing hydroxy amino acids, esters, and derivatives thereof CODEXIS, INC. 2005-09-01 US disclosed
US-20050100993-A1 Methods for producing hydroxy amino acids and derivatives thereof BIOCATALYTICS, INC. 2005-05-12 US disclosed
US-6833471-B2 Contacting beta-ketodiester having ketone and two esters with a ketoreductase under conditions permitting reduction of ketone to alcohol, regioselectively hydrolyzing one of ester groups to acid, converting acid or ester to amine BIOCATALYTICS, INC. 2004-12-21 US disclosed
US-20040053377-A1 Methods for producing hydroxy amino acids and derivatives thereof CODEXIS, INC. 2004-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053377-A1 Methods for producing hydroxy amino acids and derivatives thereof HMGCR, HSD17B12, BCKDK ALDH1A1 514/4885KDM4E 507/4885MMP8 2298/4885
US-20050100993-A1 Methods for producing hydroxy amino acids and derivatives thereof ALDH7A1, BCKDK, HSD17B12 ALDH1A1 130/4885KDM4E 167/4885MMP8 2240/4885
US-20050192439-A1 Methods for producing hydroxy amino acids, esters, and derivatives thereof ALDH7A1, BCKDK, ADH5 ALDH1A1 135/4885KDM4E 606/4885MMP8 2236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.